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PThe Prognostic Value of Normal Exercise Myocardial
Perfusion Imaging and Exercise Echocardiography
A Meta-Analysis
Louise D. Metz, MD,* Mary Beattie, MD,† Robert Hom, MD,‡ Rita F. Redberg, MD, MSC,§
Deborah Grady, MD, MPH,¶† Kirsten E. Fleischmann, MD, MPH§
New York, New York; and San Francisco, California
Objectives The purpose of this work was to determine the prognostic value of normal exercise myocardial perfusion imag-
ing (MPI) tests and exercise echocardiography tests, and to determine the prognostic value of these imaging
modalities in women and men.
Background Exercise MPI and exercise echocardiography provide prognostic information that is useful in the risk stratifica-
tion of patients with suspected coronary artery disease (CAD).
Methods We searched the PubMed, Cochrane, and DARE databases between January 1990 and May 2005, and reviewed
bibliographies of articles obtained. We included prospective cohort studies of subjects who underwent exercise
MPI or exercise echocardiography for known or suspected CAD, and provided data on primary outcomes of myo-
cardial infarction (MI) and cardiac death with at least 3 months of follow-up. Secondary outcomes (unstable
angina, revascularization procedures) were abstracted if provided. Studies performed exclusively in patients with
CAD were excluded.
Results The negative predictive value (NPV) for MI and cardiac death was 98.8% (95% confidence interval [CI] 98.5 to
99.0) over 36 months of follow-up for MPI, and 98.4% (95% CI 97.9 to 98.9) over 33 months for echocardiogra-
phy. The corresponding annualized event rates were 0.45% per year for MPI and 0.54% per year for echocardi-
ography. In subgroup analyses, annualized event rates were 1% for each MPI isotope, and were similar for
women and men. For secondary events, MPI and echocardiography had annualized event rates of 1.25% and
0.95%, respectively.
Conclusions Both exercise MPI and exercise echocardiography have high NPVs for primary and secondary cardiac events. The
prognostic utility of both modalities is similar for both men and women. (J Am Coll Cardiol 2007;49:227–37)
© 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.08.048b
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en addition to providing information regarding the diagno-
is of coronary artery disease (CAD), noninvasive tests also
rovide prognostic information useful in risk stratification
nd clinical management. Accurate risk stratification has
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006, accepted August 28, 2006.ecome increasingly important to optimize patient out-
omes and contain rapidly escalating medical care costs.
ests with high negative predictive values (NPVs) (low
vent rates after a negative test) are particularly useful
ecause they identify low-risk persons who generally do not
eed additional tests and interventions. Both stress myocar-
ial perfusion imaging (MPI) and stress echocardiography
ave prognostic value in patients suspected of having CAD,
ndependent of the information provided by clinical factors
nd the exercise electrocardiogram (1–12).
See page 238
Moreover, exercise imaging tests for the diagnosis of
AD may have variable diagnostic accuracy in women
ompared with men. The accuracy of both exercise MPI and
xercise echocardiography has been reported to be lower in
omen than in men (13).
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Prognostic Value of Exercise MPI and Echocardiography January 16, 2007:227–37We performed a systematic re-
view and meta-analysis to deter-
mine the NPV of exercise MPI,
including thallium, sestamibi,
and tetrofosmin, and exercise
echocardiography. Our second-
ary aim was to assess the NPVs
of these imaging modalities in
women and men.
Methods
Study selection. A literature
earch was performed using the PubMed, Cochrane, and
ARE databases to identify articles published between
anuary 1990 and May 2005 as part of a larger review of the
iagnostic accuracy of exercise MPI and echocardiography
n women. The following search terms were used: thallium
adioisotopes, radiopharmaceuticals, tomography emission-
omputed single-photon, technetium TC 99M sestamibi, organo-
echnetium compounds, SPECT, Cardiolite, Mibi, tetrofosmin,
echnetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane;
chocardio*, ultrasound, ultrasonography; exercise, exercise test,
xercise tolerance, exercise*, exercising, “stress test”; and diagnosis,
iagnoses, diagnostic, diagnosing, predictive values of test. The
earch was not restricted to English-language literature. Bib-
iographies of all articles obtained were reviewed to identify
dditional articles. The date limits were chosen because both
xercise echocardiography and exercise MPI using single-
hoton emission computed tomography (SPECT) with thal-
ium and sestamibi were in widespread use during this period.
Studies were included if they met the following criteria:
) prospective cohort studies of subjects who underwent
xercise SPECT MPI or exercise echocardiography for
nown or suspected CAD; 2) provided primary data on
linical outcomes of myocardial infarction or cardiac death;
) follow-up time of 3 months or more; and 4) defined a
ormal stress MPI or echocardiography test as one without
ny fixed or reversible perfusion deficit (for MPI) or fixed or
nducible wall motion abnormalities (for echocardiography).
tudies were excluded if they met the following criteria: 1)
oninvasive tests were performed exclusively in patients
fter myocardial infarction, percutaneous angioplasty, coro-
ary bypass surgery, hospitalization for unstable coronary
yndrome, or with documented CAD by angiography; 2)
ncluded pharmacologic imaging tests without presenting
ata separately for pharmacologic and exercise testing; 3)
id not include primary outcome data or event rates that
ould be statistically combined in a meta-analysis; or 4)
valuated planar MPI instead of SPECT. When multiple
tudies from the same research group were identified, only
he largest study was included to avoid potential duplication
n patient cohorts.
An initial search identified 3,563 potentially eligible
rticles. Two investigators reviewed the titles and excluded
Abbreviations
and Acronyms
CAD  coronary artery
disease
MPI  myocardial perfusion
imaging
NPV  negative predictive
value
SPECT  single-photon
emission computed
tomographyhose that clearly did not provide data on humans or did not nddress the research question. The abstracts of the remain-
ng articles were reviewed independently by 2 physician
nvestigators to determine eligibility. Disagreements were
esolved by consensus.
ata abstraction. Two investigators (L.M. and R.H.),
linded to the journal, author, year of publication, and
nstitution, independently reviewed the full text of each
otentially eligible study and abstracted data including
haracteristics of the study, participant characteristics, test
haracteristics, mean follow-up time, and percentage of the
opulation lost to follow-up. Occurrence of primary out-
omes (nonfatal myocardial infarction or cardiac death) and
econdary outcomes (revascularization and admission for
nstable angina) were recorded. Results, including number
f events or event rates based on positive or negative tests,
elative risks or hazard ratios for future events, incremental
rognostic value based on Cox proportional hazards model,
nd variables used in multivariate analysis, were abstracted.
esults stratified by gender were abstracted separately when
rovided.
uality assessment. A quality assessment was performed
y the 2 blinded investigators based on presence of the
ollowing parameters: 1) complete follow-up for 90% or
ore of the baseline cohort; 2) outcome data were obtained
y investigators blinded to the test results; and 3) whether
ospital records and death certificates were used to corrob-
rate outcomes. Studies were defined as good quality if they
ulfilled the criterion of 90% or greater follow-up and at
east 1 of the other 2 criteria. Fair-quality studies fulfilled
nly 1 of the criteria and poor-quality studies fulfilled none
f the criteria.
tatistical analysis. The primary analysis determined the
ummary estimate of the rate of myocardial infarction or
ardiac death after a normal noninvasive test. Secondary
nalysis determined summary estimates of the rate of
evascularization or unstable angina after a normal test.
ooled summary estimates and 95% confidence intervals for
vent rates after a negative noninvasive test were calculated
rom the primary data with each study result weighted by
ample size using STATA software (version 8.0, STATA
orp., College Station, Texas). These analyses were re-
eated in subgroups of studies of MPI based on the criteria
or defining a positive test, the radioisotope used, gender,
nd follow-up time. Findings were assessed for heterogene-
ty using a Q statistic, with a p value 0.10 considered
tatistically significant.
Estimated annual event rates were calculated with the
aveat that the occurrence of events may not be linear.
stimated annualized event rates for each study were
alculated as averages over the lengths of follow-up, and
ooled summary annualized event rates were calculated by
eighting study estimates by sample size.
A multivariate analysis was performed using STATA
oftware. We used weighted multiple linear regression
odels to assess the dependence of the event rate after aormal test on characteristics of each study, including
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January 16, 2007:227–37 Prognostic Value of Exercise MPI and Echocardiographyverage age of participants, percent of participants with
rior myocardial infarction, percent women, and length of
ollow-up. Analyses were weighted in proportion to the
umber of subjects in each study.
A sensitivity analysis based on study quality was per-
ormed by stratifying the studies into 2 groups, good quality
nd fair or poor quality, and calculating the summary estimates
n each group. Publication bias was assessed by calculating the
orrelation coefficient, Kendall’s tau, for the association of
ample size and event rate after a negative test (14).
esults
tudy identification. The initial literature search yielded
,563 study titles. Among these, 148 full-text articles
valuating the prognostic utility of exercise MPI or exercise
chocardiography were reviewed, and 20 studies were found
o be eligible for the systematic review. Of the 148 full-text
rticles reviewed, 17 did not address the research question
15–31), 18 were excluded because they used pharmacologic
ather than exercise stress (32–49), 27 did not include
rimary data on event rates that could be combined in a
eta-analysis (47,50–75), 16 did not address a population
ith known or suspected CAD (76–91), 5 evaluated only
ospitalized patients or patients evaluated for chest pain
yndromes in the emergency department (92–96), 16 in-
luded only patients with angiographically proven CAD or
ositive tests (97–112), 21 were potentially overlapping
atient populations of other studies (53,113–132), 5 evalu-
ted planar MPI (133–137), and 3 did not define a negative
est as one without any abnormalities (138–140).
Of the 17 studies included that evaluated MPI (141–
56), 5 used thallium (143,147,153,154,157), 8 used sesta-
tudies of the Value of Exercise Myocardial Perfusion Imaging to P
Table 1 Studies of the Value of Exercise Myocardial Perfusion
Reference
Radionuclide
Used n
Mean
Age
(yrs)
Women
(%)
Ambrosi et al. (157) Tl 84 59 28
Boyne et al. (141) MIBI 155 58 50
Chatziioannou et al. (142) MIBI 230 54 13
del Val Gomez et al. (143) Tl 85 56 53
Elhendy et al. (156) MIBI 218 53 50
Galassi et al. (144) Tetro 106 58 22
Hachamovitch et al. (155) Tl/MIBI 4,791 61 49
Kaminek et al. (145) Tl or MIBI 147 * 28
Olmos et al. (154) Tl 115 56 24
Pattillo et al. (153) Tl 196 59 29
Raiker et al. (152) MIBI 208 59 48
Schinkel et al. (151) Tetro 294 56 33
Soman et al. (150) MIBI 426 56 42
Stratmann et al. (149) MIBI 206 * 2
Sugihara et al. (148) MIBI 104 68 42
Vanzetto et al. (147) Tl 388 55 25
Zerahn et al. (146) MIBI 255 57 36
Summary estimate 8,008 54.1 33.8Patient characteristics not provided.
CI  confidence interval; MI  myocardial infarction; MIBI  sestamibi; Tetro  tetrofosmin; Tl  thalibi (141,142,146,148–150,152,156), 2 used both thallium
nd sestamibi (145,155), and 2 used tetrofosmin (144,151).
en of the 17 MPI studies measured rates of unstable
ngina and revascularization in addition to primary events
141–145,147,148,152,154,156), and 3 stratified the data by
ender (53,120,128). Of the 4 studies of exercise echocar-
iography (115,154,158,159), 2 included data on rates of
nstable angina and revascularization in addition to myo-
ardial infarction and cardiac death (154,158) and 2 strati-
ed data by gender (140,158).
redictive value of exercise MPI. The 17 exercise MPI
tudies included 8,008 subjects with a mean age of 54 years,
f whom 34% were women (Table 1). A normal MPI test
as defined as the absence of any fixed or reversible defect
n each of the studies. The risk of myocardial infarction or
ardiac death after a normal test was 1.2% with a NPV of
8.8% over a mean follow-up of 36 months, corresponding
o an estimated annualized event rate of 0.45% per year if a
resumption of linear event rates is made (Table 1). The test
f heterogeneity demonstrated that the MPI study results
re homogeneous (Q  13.06, p  0.7321).
Ten studies evaluated the predictive value of exercise
PI for cardiac revascularization or unstable angina; risk
or these events after a normal test was 3.4% with an NPV
f 96.6% over a mean follow-up of 36 months, correspond-
ng to an annualized event rate of 1.25% per year (Tables 2
nd 3).
redictive value of thallium versus sestamibi versus
etrofosmin MPI. The NPV for the risk of myocardial
nfarction or cardiac death was approximately 97% over a
ean follow-up of 45 months for thallium, approximately
9% after a normal sestamibi test over a mean follow-up of
t MI and Cardiac Death
ing to Predict MI and Cardiac Death
r Mean
Follow-Up
(Months)
Event Rate After
Negative Test (%)
(95% CI)
Negative Predictive
Value (%)
(95% CI)
Annualized
Event Rate
(%)
46 3.6 96.4 0.93
19 1.3 98.7 0.81
18 0 100 0
24 0 100 0
89 5.0 95.0 0.68
38 2.8 97.2 0.89
22 0.4 99.6 0.2
24 0.7 99.3 0.34
44 3.5 96.5 0.95
41 3.6 96.4 1.0
14 0.5 99.5 0.41
48 1.0 99.0 0.3
30 0 100 0
13 0.5 99.5 0.45
13 0 100 0
72 3.4 96.6 0.56
59 3.1 96.9 0.64
36.1 1.21 (0.98–1.48) 98.8 (98.5–99.0) 0.45redic
Imag
Prio
MI
(%)
*
27
20
*
6
55
0
*
35
47
4.8
27
6
35
18
24
51lium; Tl/MIBI  both thallium and sestamibi.
3
m
t
c
0
i
P
w
w
t
b
c
o
o
a
P
o
f
1
t
i
(
i
f
c
e
t
e
a
a
E
p
s
n
a
m
a
f
a
h
s
o
f
S
*
Sf
E
230 Metz et al. JACC Vol. 49, No. 2, 2007
Prognostic Value of Exercise MPI and Echocardiography January 16, 2007:227–372 months, over 99% when both isotopes were used over a
ean follow-up of 23 months, and 99% after a normal
etrofosmin test over a mean follow-up of 43 months. The
orresponding annualized event rates were approximately
.7% for thallium, 0.3% for sestamibi, 0.5% when both
sotopes were used, and 0.4% for tetrofosmin (Table 3).
redictive value of exercise MPI in women compared
ith men. Two studies focused on exercise MPI studies in
omen as part of larger databases included in the aforemen-
ioned summary estimates (120,128), and 1 study stratified
y gender (53). The NPVs of myocardial infarction or
ardiac death after a normal test were approximately 99%
ver an average follow-up of 32 months in women and 99%
ver 20 months in men. The annualized event rates were
pproximately 0.3% for women and 0.8% for men (Table 4).
redictive value of exercise MPI among subgroups based
n duration of follow-up. The mean duration of
ollow-up was between 1 and 3 years in 9 studies (141–
43,145,148–150,152,155), including 6,352 subjects; be-
ween 3 and 5 years in 6 studies (144,146,151,153,154,157),
ncluding 1,050 subjects; and 6 to 8 years in 2 studies
147,156), including 606 subjects. The rate of myocardial
tudies of the Value of Exercise Myocardial Perfusion Imaging to P
Table 2 Studies of the Value of Exercise Myocardial Perfusion
Reference
Radionuclide
Used n
Mean
Age
(yrs)
Women
(%)
Boyne et al. (141) MIBI 155 58 50
Chatziioannou et al. (142) MIBI 230 54 13
del Val Gomez et al. (143) Tl 85 56 53
Elhendy et al. (156) MIBI 218 53 50
Galassi et al. (144) Tetro 106 58 22
Kaminek et al. (145) Tl/MIBI 147 * 28
Olmos et al. (154) Tl 115 56 24
Raiker et al. (152) MIBI 208 59 48
Sugihara et al. (148) MIBI 104 68 42
Vanzetto et al. (147) Tl 388 55 25
Summary estimate 1,756 51.7 35.5
Patient characteristics not provided.
Abbreviations as in Table 1.
ummary Estimates of Event Rates After a Negative Test and Negaor MI and Cardiac Death, and Revascularization and Unst ble Ang
Table 3 Summary Estimates of Event Rates After a Negative Tfor MI and Cardiac Death, and Revascularization and U
Exercise Imaging Modality
and Events n
Mean
Follow-Up
(Months)
Mean
Age
(yrs)
MI and cardiac death
MPI 8,008 36 54
Thallium 868 45 57
Sestamibi 1,802 32 58
Thallium/sestamibi 4,938 23 61
Tetrofosmin 400 43 57
Echo 3,021 33 56
Revascularization and unstable angina
MPI 1,756 36 52
Echo 380 32 54cho  echocardiography; MPI  myocardial perfusion imaging; other abbreviations as in Table 1.nfarction and cardiac death was 0.7% over a mean
ollow-up of 20 months in the 1- to 3-year subgroup,
orresponding to an annualized event rate of 0.4%. The
vent rate was 2.7% over a mean follow-up of 46 months in
he 3- to 5-year subgroup, corresponding to an annualized
vent rate of 0.7%. The 6- to 8-year follow-up subgroup had
n event rate of 4% over a mean follow-up of 81 months, or
0.6% annualized event rate.
xercise echocardiography. The 4 eligible studies of the
redictive value of exercise echocardiography included 3,021
ubjects with a mean age of 56 and 46% women (Table 5). A
ormal test was defined as the absence of any wall motion
bnormalities with stress or rest in all studies. The rate of
yocardial infarction or cardiac death after a normal test was
pproximately 1.6% with an NPV of 98% over the mean
ollow-up of 33 months, corresponding to an estimated annu-
lized event rate of 0.54% (Tables 3 and 5). The test of
eterogeneity demonstrated that the exercise echocardiography
tudy results are homogeneous (Q  0.46, p  0.7952).
Two of the studies, including 380 subjects, included data
n rates of unstable angina and revascularization. The NPV
or these events was approximately 97% over a mean
t Revascularization and Unstable Angina
ing to Predict Revascularization and Unstable Angina
r Mean
Follow-Up
(Months)
Event Rate After
Negative Test (%)
(95% CI)
Negative Predictive
Value (%)
(95% CI)
Annualized
Event Rate
(%)
19 1.3 98.7 0.81
18 1.7 98.3 1.16
24 1.2 98.8 0.59
89 6.9 93.1 0.93
38 5.7 94.3 1.79
24 4.1 95.9 2.04
44 3.5 96.5 0.95
14 1.9 98.1 1.65
13 3.8 96.2 3.55
72 0.6/yr 99.4 0.60
35.5 3.42 (2.61–4.40) 96.6 (95.6–97.4) 1.25
Predictive Valuesfter a Negative Test
nd Negative Predictive Values
ble Angina After a Negative Test
men
%)
Summary Event Rate
After a Negative Test (%)
(95% CI)
Negative Predictive
Value (%)
(95% CI)
Annualized
Event Rate
(%)
4 1.21 (0.98–1.48) 98.8 (98.5–99.0) 0.45
2 3.11 (2.05–4.53) 96.9 (95.5–97.9) 0.70
5 1.28 (0.81–1.92) 98.7 (98.1–99.2) 0.34
9 0.83 (0.60–1.13) 99.2 (98.9–99.4) 0.45
8 1.5 (0.55–3.26) 98.5 (96.8–99.4) 0.42
6 1.56 (1.14–2.07) 98.4 (97.9–98.9) 0.54
6 3.42 (2.61–4.40) 96.6 (95.6–97.4) 1.25
5 2.63 (1.26–4.84) 97.4 (95.2–98.7) 0.95redic
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January 16, 2007:227–37 Prognostic Value of Exercise MPI and Echocardiographyollow-up of 32 months, corresponding to an annualized
vent rate of 0.95% (Tables 3 and 6).
redictive value of exercise echocardiography in women
nd men. Only 2 of the exercise echocardiography studies
rovided primary data stratified by gender, both of which
ound high NPVs for both men and women (140,158). The
PV was 98% in women over 38 months of follow-up, and
6% in men over 38 months of follow-up, corresponding to
nnualized event rates of 0.75% in women and 1.24% in
en (Table 4).
redictive value of exercise echocardiography among
ubgroups based on duration of follow-up. The mean
uration of follow-up was between 1 and 3 years in 2 studies
158,159), including 263 subjects, and between 3 and 4
ears in 2 studies (115,154), including 2,758 subjects. The
ate of myocardial infarction and cardiac death was approx-
mately 2% over a mean follow-up of 26 months in the 1- to
-year subgroup, corresponding to an annualized event rate
f 0.9%. The event rate was 1.5% over a mean follow-up of
0 months in the 3- to 4-year subgroup, corresponding to
n annualized event rate of 0.5%.
ultivariate analysis. Separate multivariate analyses were
erformed to determine the effect of cohort characteristics
n the NPV of the MPI and echocardiography. For MPI,
he rate of myocardial infarction and cardiac death after a
ormal test was about 0.2 percentage points higher for each
0 percentage point increase in proportion of subjects with
prior myocardial infarction. There was no significant
ifference in event rate after MPI related to percentage of
tudies of the Value of Exercise Echocardiography to Predict MI an
Table 5 Studies of the Value of Exercise Echocardiography to P
Reference n
Mean
Age
(yrs)
Women
(%)
Prior
MI
(%)
Elhendy et al. (115) 2,641 61 49 6
Ismail et al. (159) 115 53 63 *
Olmos et al. (154) 117 56 24 35
Sawada et al. (158) 148 53 48 *
Summary estimate 3,021 55.8 46
Summary Estimates of Rates After a Negative TMyocardial Infarction or Cardiac De th for WomPerfusion Imaging a d Exercise Echo
Table 4
Summary Estimates of Rates After
Myocardial Infarction or Cardiac De
Perfusion Imaging and Exercise Ech
Exercise
Imaging
Modality n
Mean
Follow-Up
(Months)
Summ
After Ne
(
MPI
All 2,900 32 1.03
Women 1,443 32 0.69
Men 1,457 20 1.37
Echo
All 5,946 37.6 3.23
Women 2,547 37.6 2.34
Men 3,399 37.6 3.90
Abbreviations as in Tables 1 and 3.Patient characteristics not provided.
CI  confidence interval; MI  myocardial infarction.omen or mean age of the cohort. For stress echocardiog-
aphy, the percentage of women in the study was the only
ariable that was significantly associated with the rates of
yocardial infarction and cardiac death after a negative test.
or each 10 percentage point increase in the proportion of
omen in the study, the event rate after a normal test was
pproximately 1 percentage point lower.
ffect of the quality of the studies on the predictive value
f noninvasive tests. Nine studies were considered good
uality (141,142,149–152,154–156) and 10 fair or poor
uality (143–148,153,157–159). For both exercise MPI and
chocardiography, event rates after a normal test were
imilar when fair- and poor-quality studies were excluded.
ublication bias. There was no evidence of significant
ublication bias for either MPI (Kendall’s tau0.29, p
.06) or exercise echocardiography studies (Kendall’s tau 
0.33, p  0.25).
iscussion
ur systematic review and meta-analysis evaluating the
rognostic utility of exercise MPI and exercise echocardi-
graphy demonstrated that the NPVs of both exercise
maging modalities are high. Although formal statistical
omparison of the tests cannot be performed due to differing
ength of follow-up, possible nonlinearity of events, and
nability to adjust fully for differences in factors that may
ffect the risk of cardiac events, the event rates with a
ormal test were low for both exercise MPI and echocardi-
rdiac Death
t MI and Cardiac Death
ean
low-Up
onths)
Event Rate After
Negative Test (%)
(95% CI)
Negative Predictive
Value (%)
(95% CI)
Annualized
Event Rate
(%)
6 1.4 98.6 0.48
3 2.6 97.4 1.36
4 3.4 96.6 0.93
8 1.4 98.6 0.19
2.8 1.56 (1.14–2.07) 98.4 (97.9–98.9) 0.54
nd Negative Predictive Value ford Men in Exercise Myoc rdial
ative Test and Negative Predictive Value for
or Women and Men in Exercise Myocardial
nt Rate
Test (%)
I)
Negative Predictive
Value (%)
(95% CI)
Annualized
Event Rate
(%)
–1.48) 99.0 (98.5–99.3) 0.58
–1.27) 99.3 (98.7–99.7) 0.33
–2.12) 98.6 (97.9–99.2) 0.82
–3.82) 96.8 (96.2–97.3) 1.03
–3.13) 97.7 (96.9–98.3) 0.75
–4.81) 96.1 (95.2–96.9) 1.24d Ca
redic
M
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stimated annualized rate of myocardial infarction or cardiac
eath was 0.45% per year after a negative MPI test, and
.54% per year after a normal echocardiography test. These
nnualized event rates are both similar to a normal age-
atched population, who carry a rate of 1% per year
160). Thus, both noninvasive imaging modalities accu-
ately identify low-risk patients.
The development of myocardial ischemia begins with
oronary stenoses, which lead initially to hypoperfusion,
ollowed by wall motion abnormalities, a temporal sequence
nown as the ischemic cascade. The later development of
all motion abnormalities in this sequence suggests that
tress MPI may be more sensitive in detecting CAD, and
herefore more useful for prognosis than stress echocardi-
graphy. However, in our analysis, we found that normal
chocardiography and MPI are both associated with low
vent rates similar to the general population.
The estimated annualized event rates for thallium, sesta-
ibi, combined thallium/sestamibi, and tetrofosmin were
ll 1%. Therefore, each of the nuclear isotopes or combi-
ation of isotopes has a high NPV and is useful in
dentification of low-risk patients.
Some studies evaluating the diagnostic accuracy of stress
lectrocardiography, MPI, and echocardiography have
ound differing tests characteristics in women compared
ith men, and there is debate as to whether any particular
odality may be more accurate in women (13,161). In our
ystematic review, both men and women with normal MPI
ests had annualized event rates of 1%. Among the 2
xercise echocardiography studies that provided data strat-
fied by gender, the annualized event rate after a normal test
as 1% in women, and about 1% in men. It is important
o note that we did not have high power to detect a
ifference in event rates between gender subgroups. How-
ver, the available data suggest that both noninvasive tests
re useful to identify low-risk patients in both men and
omen.
Subgroup analyses based on follow-up time showed a
light increase in absolute event rate with increasing
ollow-up time for MPI, with an estimated annualized event
ate 1% for each of the subgroups. Among the echocar-
iographic studies, longer duration of follow-up was not
ssociated with increased event rates. However, the longest
tudies of the Value of Exercise Echocardiography to Predict Reva
Table 6 Studies of the Value of Exercise Echocardiography to P
Reference n
Mean
Age
(yrs)
Women
(%)
Prior
MI
(%)
Olmos et al. (154) 117 56 24 35
Ismail et al. (159) 115 53 63 *
Sawada et al. (158) 148 53 48 *
Summary estimate 380 54 45
Patient characteristics not provided.
CI  confidence interval; MI  myocardial infarction.ollow-up averaged only 3 to 4 years, and the subgroup with oto 3 years of follow-up included only 263 subjects compared
ith 2,758 in the group with longer follow-up, limiting the
ower to detect a true difference between the groups.
Although events such as myocardial infarction and car-
iac death are almost universally evaluated in studies of
rognosis and are considered least susceptible to bias,
dmissions for unstable angina or heart failure, revascular-
zation, and anginal symptoms are associated with high
osts and resource utilization, as well as substantial patient
isk. In addition, as technology and medical treatments
mprove, rates of myocardial infarction and cardiac death are
ecreasing, and other outcomes, such as angina and revas-
ularization, are becoming more common (162). In our
tudy, the NPVs for revascularization and admissions for
nstable angina were high for both exercise MPI and
chocardiography. Estimated annualized event rates for
econdary events were approximately 1% per year for both
PI and echocardiography.
Stress imaging tests can be used for risk stratification (1).
ayesian analysis indicates that stress tests are most useful
or patients with intermediate pre-test probability of disease
y moving them into a higher- or lower-risk group, thereby
nforming the choice of additional diagnostic tests, inter-
entions, and medical management, which are costly and
arry significant risks. By identifying a low-risk group of
atients, defined by an annual event rate of1%, additional
nterventions can be avoided in most cases (160). Our study
ndicates that both exercise MPI and exercise echocardiog-
aphy are useful in identifying such low-risk patients over a
pectrum of pre-test probabilities. Even in study cohorts or
ubsets of patients with relatively high pre-test probability,
uch as those with a higher percentage of prior myocardial
nfarction or positive exercise treadmill tests, the primary
vent rate with normal exercise MPI or echocardiography is
elatively low (129,136,144,153). In multivariate analyses,
arkers of pre-test probability had modest effects on the
vent rates with a normal test, although there was a trend
oward increased event rates in studies having higher per-
entages of prior myocardial infarction for MPI, but not for
chocardiography.
The main limitation of our meta-analysis is that our
ummary estimates of event rates are unadjusted for some
actors that may affect risk of cardiac events. Few of the
tudies included in the analysis provided adjusted relative risks
rization and Unstable Angina
t Revascularization and Unstable Angina
ean
ow-Up
nths)
Event Rate After
Negative Test (%)
(95% CI)
Negative Predictive
Value (%)
(95% CI)
Annualized
Event Rate
(%)
4 4.3 95.7 1.17
3 0.9 99.1 0.45
8 2.7 97.3 1.16
1.7 2.63 (1.26–4.84) 97.4 (95.2–98.7) 0.95scula
redic
M
Foll
(Mo
4
2
2
3f events. Multivariate models were used in many of the
s
v
a
M
r
b
t
m
t
t
s
h
r
o
i
s
a
t
i
b
b
p
r
i
d
s
m
a
p
t
w
f
e
p
h
r
a
t
l
s
w
d
a
p
a
I
r
a
t
C
b
b
h
T
l
i
u
m
T
i
a
A
T
a
R
R
U
S
u
R
233JACC Vol. 49, No. 2, 2007 Metz et al.
January 16, 2007:227–37 Prognostic Value of Exercise MPI and Echocardiographytudies, but these models commonly assessed incremental
alue, which do not provide statistics that can be combined
cross studies.
Several studies of large cohorts undergoing exercise
PI or echocardiography were not included in this
eview due to lack of primary data that could be com-
ined in meta-analysis or inclusion of pharmacologic
ests. These studies had findings consistent with our
eta-analysis (22,38,40,54,57,60,61).
Assessments of the prognostic value of a test are suscep-
ible to referral bias or the preferential referral to further
esting or intervention in subjects with a positive test. In
tudies of prognosis, referral bias could result in a relatively
igher event rate after a negative test. Despite potential
eferral bias, the NPVs of both imaging tests were high in
ur study.
We did not include analyses of positive predictive values
n our systematic review. These values are particularly
ubject to bias due to differing patient risk factor profiles,
nd the effect of positive tests on subsequent revasculariza-
ion and medical management. Although many studies
ncluded in our meta-analysis attempted to deal with referral
ias by excluding subjects with early revascularization, this
ias persists in unadjusted results.
Spectrum bias, or variation in test performance among
ersons at higher or lower risk of disease, may also affect the
esults of prognostic studies (163). Our systematic review
ncludes studies of cohorts with varying pre-test risk of
isease, as manifested by a broad range of percentage of
ubjects with prior myocardial infarction, advanced age, and
ale gender. Estimated annualized event rates were low,
round 1% or less, for each of the studies despite varying
re-test risk of disease. Our multivariate analysis showed
hat event rates after a negative test increased minimally
ith increasing percentages of prior myocardial infarction
or MPI, and did not increase for echocardiography. How-
ver, the studies included in our review did not include
atient cohorts at higher risk of events, such as those who
ave recently had a myocardial infarction or undergone
evascularization, and those undergoing pharmacologic im-
ging tests, and should, therefore, not be generalized to
hese populations. Although our study demonstrated the
ow annualized event rate generally associated with negative
tress imaging tests, a negative test may not be associated
ith a low risk of events in certain populations, including
iabetics (39,81,82).
In addition to the prognostic utility of perfusion defects
nd wall motion abnormalities, other exercise imaging
arameters have also been shown to carry prognostic value,
lthough they were outside the scope of this meta-analysis.
n particular, Duke treadmill score (11,164,165), heart rate
ecovery (166,167), ischemic left ventricular dilation (168),
nd change in end-systolic volume (169) have been shown
o have independent prognostic value.
onclusions. Our systematic review demonstrates that
oth exercise MPI, including thallium, sestamibi, and com-ination thallium/sestamibi, and exercise echocardiography
ave high NPVs for primary and secondary cardiac events.
he event rates after normal tests with each modality are
ow, suggesting that the use of any of these noninvasive tests
s appropriate, depending on experience and cost at partic-
lar institutions. In addition, the prognostic utility of both
odalities is generally similar for both men and women.
he NPVs of exercise MPI and echocardiography are useful
n clinical practice to identify low-risk patients, thereby
voiding unnecessary tests and interventions.
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